Clinical pharmacy in Ukraine according to the healthcare professionals’ assessment

Abstract

An anonymous questionnaire survey among healthcare professionals in Ukraine (n = 10737) showed contradictions in the attitude to the peculiarities of clinical pharmacy compared to a general pharmacy, the relation to the specialists who provide clinical pharmacy services, and the healthcare settings for them. The respondents considered the activity of clinical pharmacist necessary in 74.2%. The community pharmacies were identified as prior professional settings for clinical pharmacists in 55.3%; hospitals – 47.7%, hospital pharmacies – 45.0%. Among the directions of the clinical pharmacist’s activity at the hospital, monitoring of drug safety and efficacy was stated by 69.9%, provision of the pharmaceutical care – 50.5%, evaluation of pharmacotherapy – 42.1%, processing of the local drug formulary – 26.8%. The respondents saw prospects for the development of clinical pharmacy in Ukraine in 54.2%. Therefore, there were differences in views on the key issues of clinical pharmacy throughout Ukraine and the insufficient support for its prospects.

The acceptance and awareness of healthcare providers towards doctor of pharmacy (Phram D) in the Palestinian health care system

“…These facts gain the HCPs good knowledge about the importance of implementation of clinical pharmacists in healthcare settings. These results consistent with what found in studies performed in the United Arab Emirates ( Abu-Gharbieh et al, 2010 ), Saudi Arabia ( Al-Arifi et al, 2015 ), Kuwait ( Matowe et al, 2006 ), Jordan ( Tahaineh et al, 2009 ), Sudan ( Awad et al, 2007 ), Egypt ( Sabry and Farid, 2014 ) and Ukraine( Zimenkovsky et al, 2019 ). Our study showed the presence of a small group who is < 25 years and > 56 years old they have no idea about clinical pharmacist; which may be due to the absence of clinical pharmacist application clinically in the Palestinian health system, the absence of Pharm D program in most of the Palestinian universities, the low experience of young professionals in the clinical world and the absence of keeping up with the new specialty among older ones ( Bell et al, 2009 ).…”

Synthetic strategies and medicinal perspectives of 4‐thiazolidinones: Recent developments and structure–activity relationship studies

“…The success of research in a particular field can be gauged from the number of patents granted in that field. This section deals with patents on 4‐thiazolidinones in the last decade in the fields of anticonvulsant, antiinflammatory, anticancer, and other biological activities as enlisted in the Table 1 [61–99]. These patents impress upon the synthetic progress and pharmacological advances pertaining to this motif thus emphasizing its crucial role.…”